PsA, SpA
Conditions
Keywords
Seronegative Inflammatory Arthritis, SpA, PsA, Randomized, Behavioural Change
Brief summary
Rheumatologists treating patients with seronegative arthritis will be randomized to treat their patients to a target or to treat their patients under their usual standard of care. All physicians will perform an initial chart audit. Following the initial chart audit, all physicians in the treat-to-target group will receive accredited educational training. Six months after the initial chart audit, all physicians will perform a repeat audit to see if patients are assessed more systematically and treated to a target of low disease state.
Interventions
BEHAVIORALEducation and Feedback
Rheumatologists are rated on how systematically they assess their patients, and receive six sessions of university accredited education about systematic assessments of patients with seronegative arthritis.
Sponsors
Academic Medical Organization of Southwestern Ontario
Abbott
Pope Research Corporation
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Canadian Rheumatologist
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Improvement of Systematic Assessments | November 2012 - November 2013 | Physicians in the Education and Feedback arm are assessed via a needs assessment to identify the care gaps for their patients with inflammatory arthritis. After the education and feedback, they complete a second chart audit and their improvements in assessments is recorded. |
Countries
Canada
Outcome results
None listed